A 3D human liver model of nonalcoholic steatohepatitis
M. Duriez, L. Hoet, A. Jacquet, S. Roche, M.-D. Bock, C. Rocher, G. Haussy, X. Vige, Z. Bocskei, T. Slavnic, V. Martin, J.-C. Guillemot, M. Didier, A. Kannt, C. Orsini, V. Mikol, A.-C. Le Fevre
Abstract
AO_SCPLOWBSTRACTC_SCPLOWWe have developed an in vitro preclinical 3D Non-Alcoholic SteatoHepatitis (NASH) model by co-culturing four human primary liver cell types: hepatocytes, stellate, endothelial and Kupffer cells. Cells were embedded in a hydrogel of rat collagen in 96-well plate and a NASH-like environment was induced with a medium containing free fatty acids (FFAs) and tumor necrosis factor (TNF). This model was characterized by biochemical, imaging and transcriptomics analysis. On the one hand, we succeed in defining suitable culture conditions to maintain the 3D co-culture up to 10 days in vitro with the lowest level of steatosis, and reproducible low levels of inflammation and fibrosis. On the other hand, we induced NASH disease with a custom medium mimicking NASH features (hepatocyte injury, steatosis, inflammation and fibrosis). The 10-day cell viability and cost effectiveness of the model make it suitable for medium throughput drug screening and provide attractive avenues to better understand disease physiology and to identify and characterize new drug targets. SO_SCPLOWUMMARYC_SCPLOWWe developed a 3D human liver model which exhibits many features of non-alcoholic steatohepatitis and that could become a platform for medium throughput drug screening.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Novel 3D Approach to Model Non-Alcoholic Fatty Liver Disease using human Pluripotent Stem Cells
Carola Maria Morell, Samantha Grace Tilson, … Ludovic Vallier·bioRxiv·Feb 7, 2024
- A fully defined pluripotent stem cell derived multi-liver-cell model for steatohepatitis and fibrosis
M. K. Gautam, B. Toprakhisar, … C. M. Verfaillie·bioRxiv·Sep 3, 2020
- Generation of liver organoids from human induced pluripotent stem cells as liver fibrosis and steatosis models
H. Y. Tsang, P. H. Y. Lo, K. K. H. Lee·bioRxiv·Jun 29, 2021
- Secreted folate receptor-gamma drives fibrogenesis in nonalcoholic steatohepatitis by amplifying TGFβ signaling in hepatic stellate cells
S. Merali, C. Quinn, … S. L. Friedman·bioRxiv·Jul 21, 2022
- Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of non-alcoholic steatohepatitis
T. Duparc, F. Briand, … L. O. Martinez·bioRxiv·May 17, 2019
- Integrated gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease
J. Yang, Y. Hirai, … K.-i. Kamei·bioRxiv·Jun 10, 2020